Effect of telomere and telomerase interactive agents on human tumor and normal cell lines

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 987-993

  Rha, Sun Young ^a,e   Izbicka, Elzbieta ^a   Lawrence, Richard ^a   Davidson, Karen ^a   Sun, Daekyu ^a   Moyer, Mary Pat ^b,d   Roodman, G David ^b   Hurley, Lawrence ^c   Von Hoff, Daniel ^a  

^a CTRC Institute for Drug Development   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d NONE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PORPHYRIN DERIVATIVE; TELOMERASE; ZIDOVUDINE;

ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; INTESTINE CELL; KERATINOCYTE; PRIORITY JOURNAL; TELOMERE; TUMOR CELL;

BONE MARROW CELLS; CELL COUNT; CELL DIVISION; CELL LINE; COLONY-FORMING UNITS ASSAY; HELA CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIGHT; PORPHYRINS; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED; ZIDOVUDINE;

EID: 0000659099     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Shay, J. W., Pereira-Smith, O. M., and Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res., 196: 33-39, 1991.
2. Wright, W. E., Pereira-Smith, O. M., and Shay, J. W. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol., 9: 3088-3092, 1989.
3. Kim, N. W., Piatyszek, M. A, Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
4. de Lange, T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA, 91: 2882-2885, 1994.
5. Landberg, G., Nielsen, N. H., Nilsen, P., Emdin, S. O., Cajander, J., and Roos, G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res., 57: 549-554, 1997.
6. Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A. B., Wright, W. E., and Shay, J. W. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res., 2: 799-803, 1996.
7. Parkinson, E. K. Do telomerase antagonists represent a novel anticancer strategy? Br. J. Cancer, 73: 1-4, 1996.
8. Sharma, S., Raymond, E., Soda, H., Sun, S., Hilsenbeck, S., Sharma, A., Izbicka, E., Windle, B., and Von Hoff, D. D. Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann. Oncol., 8: 1063-1074, 1997.
9. Raymond, E., Sun, D., Chen, S. F., Windle, B., and Von Hoff, D. D. Agents that target telomerase and telomeres. Pharm. Biotech., 7: 583-591, 1996.
10. Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., and Hurley, L. Inhibition of human telomerase by a G-Quadruplex-interactive compounds. J. Med. Chem., 40: 2113-2116, 1997.
11. Wheelhouse, R. T., Sun, D., Han, H., Han, F. X., and Hurley, L. H. Cationic porphyrin as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridol) porphyrine with quadruplex DNA. J. Am. Chem. Soc., 120: 3261-3262, 1998.
12. Izbicka, E., Wheelhouse, R. T., Raymond, E., Davidson, K. K., Lawrence, R. A., Sun, D., Windle, B. E., Hurley, L. H., and Von Hoff, D. D. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res., 59: 639-644, 1999.
13. Schevchenko, A., Mann, M., Lundblad, V., and Cech, T. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science (Washington DC), 276: 561-567, 1997.
14. Nakayama, J., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Tahara, E., Ide, T., and Ishikawa, F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 18: 65-68, 1998.
15. Kondo, S., Tanaka, Y., Kondo, Y., Hitomi, M., Barnett, G. H., Ishizaka, Y., Liu, J., Haqqi, T., Nishiyama, A., Villeponteau, B., Cowell, J. K., and Barna, B. P. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J., 12: 801-811, 1998.
16. Strahl, C., and Blackburn, E. H. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res., 22: 893-900, 1994.
17. Yegorov, Y. E., Chernov, D. N., Akimov, S. S., Akhmalisheva, A. K., Smirnova, Y. B., Shinkarev, D. B., Semenova, I. V., Yegorova, I. N., and Zelenin, A. V. Blockade of telomerase function by nucleoside analogs. Biochemisty, 62: 1296-1305, 1997.
18. Izbicka, E., Nishioka, D., Marcell., V., Raymond, E., Davidson, K. K., Lawrence, R. A., Wheelhouse, R. T., Hurley, L. H., Wu, R. S., and Von Hoff, D. D. Telomere-interactive agents affect proliferation rates and induce cromosomal destabilization in sea urchin embryos. Anticancer Drug Design, 14: 355-365, 1999.
19. Hsiao, R., Sharma, H. W., Ramakrishnan, S., Keith, E., and Narayanan, R. Telomerase activity in normal human endothelial cells. Anticancer Res., 17: 827-832, 1997.
20. Kyo, S., Takakura, M., Kohama, T., and Inoue, M. Telomerase activity in human endometrium. Cancer Res., 57: 610-614, 1997.
21. Harle-Bachor, C., and Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA, 93: 6476-6481, 1996.
22. Tsao, J. L., Lukas, J., Yang, X., Shah, A., Press, M., and Shibata, D. Telomerase activity in normal and neoplastic breast. Clin. Cancer Res., 3: 627-631, 1997.
23. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., and Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 155: 3711-3715, 1995.
24. Chiu, C. P., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., and Landsdorp, P. M. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells, 14: 239-248, 1996.
25. Yui, J., Chiu, C. P., and Lansdorp, P. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood, 91: 3255-3262, 1998.
26. Counter, C. M., Gupta, J., Harley, C. B., Leber, B., and Bacchetti, S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85: 2315-2320, 1995.
27. Bednarek, A., Budunova, I., Slaga, T. J., and Aldaz, M. Increased telomerase activity in mouse skin premalignant progression. Cancer Res., 55: 4566-4569, 1995.
28. Moyer, M. P., Manzano, L. A., Merriman, R. L., Stauffer, J. S., and Tanzer, L. R. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell. Dev. Biol., 32:315-317, 1996.
29. Sun, D., Hurley, L. H., and Von Hoff, D. D. Telomerase assay using biotinylated-primer extension and magnetic separation of the products. BioTechniques, 25: 1046-1051, 1998.
30. Demulder, A., Takahashi, S., Singer, F. R., Hosking, D. J., and Roodman, G. D. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. Endocrinology, 133: 1978-1982, 1993.
31. Fritsch, C., Lang, K., Neuse, W., Ruzicka, T., and Lehmann, P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol. Appl. Skin Physiol., 11: 358-373, 1998.
32. Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., and de Lange, T. A human telomeric protein. Science (Washington DC), 270: 1663-1667, 1995.
33. Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Amgen EST Program, Bass, M. D., Arruda, I., and Robinson, M. D. A mammalian telomerase-associated protein. Science (Washington DC), 275: 973-977, 1997.
34. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. Mammalian telomeres end in a large duplex loop. Cell. 97: 503-514, 1999.
35. Georgiou, G. N., Ahmet, M. T., Houlton, A., Silver, J., and Cherry, R. J. Measurement of the rate of uptake and subcellular localization of porphyrins in cells using fluorescence digital imaging microscopy. Photochem. Photobiol., 59: 419-422, 1994.
36. Villanueva, A., and Jori, G. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine. Cancer Lett., 73: 59-64, 1993